Evidence map›Paper›PMID 31581876›Full record

Observational studyJournal of the American Heart Association2019

Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study.

Rui Providência, Pedro Adragão, Carlo de Asmundis, Julian Chun, Gianbattista Chierchia, Pascal Defaye, Frédéric Anselme, Antonio Creta, Pier D Lambiase, Boris Schmidt and 11 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Venous vascular closure system vs. figure-of-eight suture following atrial fibrillation ablation: the STYLE-AF Study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  7. Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2021
    Trial
  8. Review
  9. Article
  10. Modifiable Risk Factors in Atrial Fibrillation: Clinical Implications and Pathophysiological Insights.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2026
    Review
  11. Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Acute outcomes of cryoballoon vs. circular vs. pentaspline pulsed-field ablation catheters in combined pulmonary vein isolation and roof line ablation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  16. Article
  17. Article
  18. Impact of venous closure systems on time to ambulation and discharge following AF ablation: a systematic review and meta-analytic review.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Review
  19. Review
  20. Multimorbidity increases risk of atrial fibrillation recurrence after cryoballoon ablation.International journal of cardiology. Heart & vasculature · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Rui ProvidênciaClinic Pasteur of Toulouse Toulouse France.
Pedro AdragãoCardiology Department Hospital de Santa Cruz Lisbon Portugal.
Carlo de AsmundisHeart Rhythm Management Centre Universiteit Ziekenhuis Brussel Belgium.
Julian ChunCardioangiologisches Centrum Bethanien Medizinische Klinik III, Markus Krankenhaus Frankfurt am Main Germany.
Gianbattista ChierchiaHeart Rhythm Management Centre Universiteit Ziekenhuis Brussel Belgium.
Pascal DefayeCHU Michallon Grenoble France.
Frédéric AnselmeUniversity Hospital Rouen France.
Antonio CretaSt. Bartholomew's Hospital Barts Health NHS Trust London United Kingdom.
Pier D LambiaseSt. Bartholomew's Hospital Barts Health NHS Trust London United Kingdom.
Boris SchmidtCardioangiologisches Centrum Bethanien Medizinische Klinik III, Markus Krankenhaus Frankfurt am Main Germany.
Shaojie ChenCardioangiologisches Centrum Bethanien Medizinische Klinik III, Markus Krankenhaus Frankfurt am Main Germany.
Diogo CavacoCardiology Department Hospital de Santa Cruz Lisbon Portugal.
Ross J HunterSt. Bartholomew's Hospital Barts Health NHS Trust London United Kingdom.
João CarmoCardiology Department Hospital de Santa Cruz Lisbon Portugal.
Stephane CombesClinic Pasteur of Toulouse Toulouse France.
Shohreh HonarbakhshCardiology Department Hospital de Santa Cruz Lisbon Portugal.
Nicolas CombesClinic Pasteur of Toulouse Toulouse France.
Maria João SousaClinic Pasteur of Toulouse Toulouse France.
Zeynab JebberiClinic Pasteur of Toulouse Toulouse France.
Jean-Paul AlbenqueClinic Pasteur of Toulouse Toulouse France.
Serge BovedaClinic Pasteur of Toulouse Toulouse France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Outcomes of catheter ablation of atrial fibrillation (AF) are variable and the predictors of success require further elucidation since the identification of correctable risk factors could help to optimize therapy. We aimed to assess the impact of body mass index (BMI) in the overall safety and efficacy of catheter ablation of AF, with emphasis on the use of cryoballoon ablation and novel oral anticoagulants. Methods and Results There were 2497 consecutive patients undergoing catheter ablation of AF in 7 European high volume centers were stratified according to BMI (normal weight <25 kg/m

Indexed as

Body Mass IndexAtrial FibrillationCatheter AblationComorbidityEuropeFemaleHumansIncidenceMaleMiddle AgedObesityRecurrenceRisk AssessmentRisk FactorsSurvival Rateatrial fibrillationmetabolic syndromeobesitysinus rhythmvascular complications

Identifiers

PMID31581876
PMCPMC6818047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.